ATE275192T1 - Neue therapeutische verwendungen der heterologen superoxiddismutasen (hsd), sowie verfahren zur selektierung dieser hsd - Google Patents

Neue therapeutische verwendungen der heterologen superoxiddismutasen (hsd), sowie verfahren zur selektierung dieser hsd

Info

Publication number
ATE275192T1
ATE275192T1 AT99900513T AT99900513T ATE275192T1 AT E275192 T1 ATE275192 T1 AT E275192T1 AT 99900513 T AT99900513 T AT 99900513T AT 99900513 T AT99900513 T AT 99900513T AT E275192 T1 ATE275192 T1 AT E275192T1
Authority
AT
Austria
Prior art keywords
hsd
selecting
therapeutic uses
heterologue
methods
Prior art date
Application number
AT99900513T
Other languages
English (en)
Inventor
Bernard Dugas
Alphonse Calenda
Jacques Sauzieres
Eric Postaire
Original Assignee
Isocell
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isocell filed Critical Isocell
Application granted granted Critical
Publication of ATE275192T1 publication Critical patent/ATE275192T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0089—Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Psychiatry (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
AT99900513T 1998-01-12 1999-01-12 Neue therapeutische verwendungen der heterologen superoxiddismutasen (hsd), sowie verfahren zur selektierung dieser hsd ATE275192T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9800205A FR2773488B1 (fr) 1998-01-12 1998-01-12 Nouvelles utilisations therapeutiques des superoxyde dismutases heterologues (hsd), ainsi que procede de selection desdites hsd
PCT/FR1999/000031 WO1999035247A1 (fr) 1998-01-12 1999-01-12 Nouvelles utilisations therapeutiques des superoxyde dismutases heterologues (hsd), ainsi que procede de selection desdites hsd

Publications (1)

Publication Number Publication Date
ATE275192T1 true ATE275192T1 (de) 2004-09-15

Family

ID=9521662

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99900513T ATE275192T1 (de) 1998-01-12 1999-01-12 Neue therapeutische verwendungen der heterologen superoxiddismutasen (hsd), sowie verfahren zur selektierung dieser hsd

Country Status (7)

Country Link
US (1) US6426068B1 (de)
EP (1) EP1047769B1 (de)
JP (1) JP3875022B2 (de)
AT (1) ATE275192T1 (de)
DE (1) DE69919840D1 (de)
FR (1) FR2773488B1 (de)
WO (1) WO1999035247A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2645674A1 (en) * 2006-03-15 2007-09-20 Isocell Pharma S.A. Pharmaceutical compositions comprising sods and prolamine based peptide fragments
EP3406244B1 (de) 2009-04-15 2023-06-07 BMG Pharma S.p.A. Zusammensetzungen enthaltend zinkgluconat und taurin für schleimhaut- und hautbeschwerden

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5714362A (en) * 1983-04-29 1998-02-03 Yeda Research And Development Co. Ltd. Human superoxide dismutase cDNA
US5196335A (en) * 1983-04-29 1993-03-23 Yeda Research And Development Co., Ltd. Human superoxide dismutase cDNA

Also Published As

Publication number Publication date
FR2773488A1 (fr) 1999-07-16
DE69919840D1 (de) 2004-10-07
WO1999035247A1 (fr) 1999-07-15
US6426068B1 (en) 2002-07-30
JP2002500236A (ja) 2002-01-08
EP1047769B1 (de) 2004-09-01
FR2773488B1 (fr) 2000-03-24
EP1047769A1 (de) 2000-11-02
JP3875022B2 (ja) 2007-01-31

Similar Documents

Publication Publication Date Title
ATE514772T1 (de) Multipotente erwachsene stammzellen und verfahren zu deren isolierung
ATE415962T1 (de) Verwendung von asiatsäure oder asiaticosid zur behandlung von krebs
DE69525151D1 (de) Methoden zur krankheitsbehandlung unter verwendung von sertoli-zellen und allotransplantat oder xenotransplantat
ATE380548T1 (de) Verwendung von p53 inhibitoren zur behandlung von nebenerscheinungen bei der krebstherapie
WO2003000707A3 (en) Antisense modulation of superoxide dismutase 1, soluble expression
DE69939312D1 (de) Verfahren zur identifizierung von induktoren und inhibitoren proteolytischer antikörper, zusammensetzungen sowie deren verwendungen
HUP0002095A2 (hu) Vegyületek prosztatarák immunterápiás kezelésére és alkalmazásuk
ATE296839T1 (de) Antikörper zur krebsbehandlung und -diagnose
ATE509004T1 (de) 3-alkylierte 5,5',6,6',7,7',8,8'-octahydro-2, 2'binaphthole und 3,3'-dialkylierte 5,5',6,6',7, 7',8,8'-octahydro-2,2'-binaphthole sowie herstellungsverfahren dafür
DE3785424D1 (de) Verschleisskoerper und pulver sowie verfahren zur herstellung.
SG149000A1 (en) Gag binding proteins
TNSN06059A1 (en) Use of polypeptides of the cupredoxin family in cancer therapy
ATE407677T1 (de) Gereinigte zubereitungen von 10-propargyl-10- deazaaminopterin und verfahren zu ihrer verwendung in der tumorbehandlung
ATE275192T1 (de) Neue therapeutische verwendungen der heterologen superoxiddismutasen (hsd), sowie verfahren zur selektierung dieser hsd
ATE252383T1 (de) Verwendung von 2-methyl-thiazolidin-2,4- dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen
ATE548048T1 (de) Oncomodulin zur behandlung von neurologishen erkrankungen
DE69806093D1 (de) Maske zur Herstellung von laminierten dreidimensionalen Gegenstände, sowie dessen Herstellungs- und Gebrauchsverfahren
ATE314066T1 (de) Verwendung von buprenorphin zur therapie der harninkontinenz
AU4037299A (en) Genetically-modified fibroblasts and the use thereof
WO2001094409A3 (en) Compositions and methods for the therapy and diagnosis of pancreatic cancer
ATE435284T1 (de) Zusammensetzungen und verfahren zur therapie und diagnose von lungenkrebs
WO2002012331A3 (en) Compositions and methods for the therapy and diagnosis of pancreatic cancer
DE50203224D1 (de) Gelenkimplantat sowie verfahren zum herstellen eines solchen
WO2004009028A3 (en) Method and composition for treating and preventing influenza infection and symptoms thereof
WO2004049917A3 (en) Methods of therapy and diagnosis using targeting of cells that express ly-9

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties